Abstract
Renal function evaluation is a key factor in the long-term follow-up of patients with neurogenic bladder dysfunction. It is as crucial as complex, since many of the tests available nowadays, lack accuracy, particularly in this group of patients [1]. Lawrenson et al. showed that patients with neural tube defects have an eightfold greater risk of developing renal failure, whereas spinal cord injury patients present a fivefold greater risk [2]. As it would be expected, this risk increases exponentially with age. In multiple sclerosis, the overall risk of upper tract damage is considerably lower, being almost similar to the general population [3–5]. Whatever the neurological condition, an accurate renal function evaluation is then key to early diagnosis and follow-up of various kidney diseases in this group of patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Castro MJ, Apple DF, Hillegass EA, Dudley GA. Influence of complete spinal cord injury on skeletal muscle cross-sectional area within the first 6 months of injury. Eur J Appl Physiol. 1999;80:373–8.
Lawrenson R, Wyndaele JJ, Vlachonikolis I, Farmer C, Glickman S. Renal failure in patients with neurogenic lower urinary tract dysfunction. Neuroepidemiology. 2001;20:138–43.
Sirls LT, Zimmern PE, Leach GE. Role of limited evaluation and aggressive medical management in multiple sclerosis: a review of 113 patients. J Urol. 1994;151:946–50.
Collins CW, Winters JC, American Urological Association, Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction. AUA/SUFU adult urodynamics guideline: a clinical review. Urol Clin North Am. 2014;41:353–62.
Fletcher SG, Dillon BE, Gilchrist AS, Haverkorn RM, Yan J, Frohman EM, et al. Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler. 2013;19:1169–74.
Blok B, et al. EAU guidelines on neuro-urology. Uroweb. 2015 [cited 2017 Mar 15]. http://uroweb.org/guideline/neuro-urology/.
Ruffion A, de Sèze M, Denys P, Perrouin-Verbe B, Chartier-Kastler E, Groupe d’Etudes de Neuro-Urologie de Langue Française. Groupe d’Etudes de Neuro-Urologie de Langue Française (GENULF) guidelines for the management of spinal cord injury and spina bifida patients. Prog Urol. 2007;17:631–3.
Traynor J, Mactier R, Geddes CC, Fox JG. How to measure renal function in clinical practice. BMJ. 2006;333:733–7.
Bröchner-Mortensen J, Rödbro P. Selection of routine method for determination of glomerular filtration rate in adult patients. Scand J Clin Lab Invest. 1976;36:35–43.
Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT. Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol. 2010;5:1003–9.
Chasis H, Smith HW. The excretion of urea in normal man and in subjects with glomerulonephritis. J Clin Invest. 1938;17:347–58.
Deinum J, Derkx FH. Cystatin for estimation of glomerular filtration rate? Lancet. 2000;356:1624–5.
Risch L, Herklotz R, Blumberg A, Huber AR. Effects of glucocorticoid immunosuppression on serum cystatin C concentrations in renal transplant patients. Clin Chem. 2001;47:2055–9.
Kos J, Stabuc B, Cimerman N, Brünner N. Serum cystatin C, a new marker of glomerular filtration rate, is increased during malignant progression. Clin Chem. 1998;44:2556–7.
Collé A, Tavera C, Prévot D, Leung-Tack J, Thomas Y, Manuel Y, et al. Cystatin C levels in sera of patients with human immunodeficiency virus infection. A new avidin-biotin ELISA assay for its measurement. J Immunoassay. 1992;13:47–60.
Mingat N, Villar E, Allard J, Castel-Lacanal E, Guillotreau J, Malavaud B, et al. Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology. 2013;82:1032–7.
Boubaker A, Prior JO, Meuwly J-Y, Bischof-Delaloye A. Radionuclide investigations of the urinary tract in the era of multimodality imaging. J Nucl Med. 2006;47:1819–36.
Taylor AT. Radionuclides in nephrourology, part 2: pitfalls and diagnostic applications. J Nucl Med. 2014;55:786–98.
Gordon I, Colarinha P, Fettich J, Fischer S, Frökier J, Hahn K, et al. Guidelines for standard and diuretic renography in children. Eur J Nucl Med. 2001;28:BP21–30.
Piepsz A, Ismaili K, Hall M, Collier F, Tondeur M, Ham H. How to interpret a deterioration of split function? Eur Urol. 2005;47:686–90.
Wang Y-T, Chiu N-T, Chen M-J, Huang J-J, Chou H-H, Chiou Y-Y. Correlation of renal ultrasonographic findings with inflammatory volume from dimercaptosuccinic acid renal scans in children with acute pyelonephritis. J Urol. 2005;173:190–4.
Kovanlikaya A, Okkay N, Cakmakci H, Ozdoğan O, Degirmenci B, Kavukcu S. Comparison of MRI and renal cortical scintigraphy findings in childhood acute pyelonephritis: preliminary experience. Eur J Radiol. 2004;49:76–80.
Ritchie G, Wilkinson AG, Prescott RJ. Comparison of differential renal function using technetium-99m mercaptoacetyltriglycine (MAG3) and technetium-99m dimercaptosuccinic acid (DMSA) renography in a paediatric population. Pediatr Radiol. 2008;38:857–62.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature B.V.
About this chapter
Cite this chapter
Grilo, N., Schurch, B. (2019). Renal Function Evaluation. In: Liao, L., Madersbacher, H. (eds) Neurourology. Springer, Dordrecht. https://doi.org/10.1007/978-94-017-7509-0_21
Download citation
DOI: https://doi.org/10.1007/978-94-017-7509-0_21
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-017-7507-6
Online ISBN: 978-94-017-7509-0
eBook Packages: MedicineMedicine (R0)